{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:20:15Z","timestamp":1790601615564,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["74580"],"award-info":[{"award-number":["74580"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UAG063911"],"award-info":[{"award-number":["UAG063911"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UG3 NS103870"],"award-info":[{"award-number":["UG3 NS103870"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004727","name":"Vlaams Instituut voor Biotechnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004727","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Flanders Research Foundation"},{"DOI":"10.13039\/100003607","name":"Association for Frontotemporal Degeneration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00401-022-02531-3","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:07:22Z","timestamp":1671282442000},"page":"285-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging"],"prefix":"10.1007","volume":"145","author":[{"given":"Jolien","family":"Perneel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bavo","family":"Heeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Van den Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wynants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina T.","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Faura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-2972","authenticated-orcid":false,"given":"Ian R. A.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"2531_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.biopsych.2014.03.006","volume":"76","author":"HH Adams","year":"2014","unstructured":"Adams HH, Verhaaren BF, Vrooman HA, Uitterlinden AG, Hofman A, van Duijn CM et al (2014) TMEM106B influences volume of left-sided temporal lobe and interhemispheric structures in the general population. Biol Psychiatry 76:503\u2013508. https:\/\/doi.org\/10.1016\/j.biopsych.2014.03.006","journal-title":"Biol Psychiatry"},{"key":"2531_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916\u2013919. https:\/\/doi.org\/10.1038\/nature05016","journal-title":"Nature"},{"key":"2531_CR3","doi-asserted-by":"publisher","first-page":"19670","DOI":"10.1074\/jbc.M113.515700","volume":"289","author":"OA Brady","year":"2014","unstructured":"Brady OA, Zhou X, Hu F (2014) Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a). J Biol Chem 289:19670\u201319680. https:\/\/doi.org\/10.1074\/jbc.M113.515700","journal-title":"J Biol Chem"},{"key":"2531_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/2051-5960-1-36","volume":"1","author":"JI Busch","year":"2013","unstructured":"Busch JI, Martinez-Lage M, Ashbridge E, Grossman M, Van Deerlin VM, Hu F et al (2013) Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Acta Neuropathol Commun 1:36. https:\/\/doi.org\/10.1186\/2051-5960-1-36","journal-title":"Acta Neuropathol Commun"},{"key":"2531_CR5","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang A, Xiang X, Wang J, Lee C, Arakhamia T, Simjanoska M et al (2022) Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185:1346-1355.e15. https:\/\/doi.org\/10.1016\/j.cell.2022.02.026","journal-title":"Cell"},{"key":"2531_CR6","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin AS, Unger TL, Gallagher MD, Bill E, Kwong LK, Volpicelli-Daley L et al (2012) TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J Neurosci 32:11213\u201311227. https:\/\/doi.org\/10.1523\/JNEUROSCI.0521-12.2012","journal-title":"J Neurosci"},{"key":"2531_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"key":"2531_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan AJ, Nelson PT, Katsumata Y, Shade LMP, Boehme KL, Teylan MA et al (2021) Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun 9:152. https:\/\/doi.org\/10.1186\/s40478-021-01250-2","journal-title":"Acta Neuropathol Commun"},{"key":"2531_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050219","volume":"21","author":"T Feng","year":"2020","unstructured":"Feng T, Mai S, Roscoe JM, Sheng RR, Ullah M, Zhang J et al (2020) Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice. EMBO Rep 21:e50219. https:\/\/doi.org\/10.15252\/embr.202050219","journal-title":"EMBO Rep"},{"key":"2531_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awaa154","volume":"143","author":"T Feng","year":"2020","unstructured":"Feng T, Sheng RR, Sol\u00e9-Dom\u00e8nech S, Ullah M, Zhou X, Mendoza CS et al (2020) A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Brain 143:2255\u20132271. https:\/\/doi.org\/10.1093\/brain\/awaa154","journal-title":"Brain"},{"key":"2531_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-020-02246-3","volume":"141","author":"T Feng","year":"2021","unstructured":"Feng T, Lacrampe A, Hu F (2021) Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders. Acta Neuropathol 141:327\u2013339. https:\/\/doi.org\/10.1007\/s00401-020-02246-3","journal-title":"Acta Neuropathol"},{"key":"2531_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-022-01334-7","volume":"10","author":"T Feng","year":"2022","unstructured":"Feng T, Luan L, Katz II, Ullah M, Van Deerlin VM, Trojanowski JQ et al (2022) TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss. Acta Neuropathol Commun 10:33. https:\/\/doi.org\/10.1186\/s40478-022-01334-7","journal-title":"Acta Neuropathol Commun"},{"key":"2531_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1212\/WNL.0b013e31820a0e3b","volume":"76","author":"N Finch","year":"2011","unstructured":"Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M et al (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76:467\u2013474. https:\/\/doi.org\/10.1212\/WNL.0b013e31820a0e3b","journal-title":"Neurology"},{"key":"2531_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-013-1239-x","volume":"127","author":"MD Gallagher","year":"2014","unstructured":"Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC et al (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol 127:407\u2013418. https:\/\/doi.org\/10.1007\/s00401-013-1239-x","journal-title":"Acta Neuropathol"},{"key":"2531_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajhg.2017.09.004","volume":"101","author":"MD Gallagher","year":"2017","unstructured":"Gallagher MD, Posavi M, Huang P, Unger TL, Berlyand Y, Gruenewald AL et al (2017) A dementia-associated risk variant near TMEM106B alters chromatin architecture and gene expression. Am J Hum Genet 101:643\u2013663. https:\/\/doi.org\/10.1016\/j.ajhg.2017.09.004","journal-title":"Am J Hum Genet"},{"key":"2531_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/jnnp-2017-315641","volume":"88","author":"SR Harding","year":"2017","unstructured":"Harding SR, Bocchetta M, Gordon E, Cash DM, Cardoso MJ, Druyeh R et al (2017) The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort. J Neurol Neurosurg Psychiatry 88:997\u2013998. https:\/\/doi.org\/10.1136\/jnnp-2017-315641","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2531_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang YX, Cao Q, Sawaya MR, Abskharon R, Ge P, DeTure M et al (2022) Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature 605:304\u2013309. https:\/\/doi.org\/10.1038\/s41586-022-04670-9","journal-title":"Nature"},{"key":"2531_CR18","doi-asserted-by":"publisher","first-page":"19355","DOI":"10.1074\/jbc.M112.365098","volume":"287","author":"CM Lang","year":"2012","unstructured":"Lang CM, Fellerer K, Schwenk BM, Kuhn PH, Kremmer E, Edbauer D et al (2012) Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration. J Biol Chem 287:19355\u201319365. https:\/\/doi.org\/10.1074\/jbc.M112.365098","journal-title":"J Biol Chem"},{"key":"2531_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00401-019-02066-0","volume":"139","author":"Z Li","year":"2020","unstructured":"Li Z, Farias FHG, Dube U, Del-Aguila JL, Mihindukulasuriya KA, Fernandez MV et al (2020) The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathol 139:45\u201361. https:\/\/doi.org\/10.1007\/s00401-019-02066-0","journal-title":"Acta Neuropathol"},{"key":"2531_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/bpa.12924","volume":"31","author":"JJ Llibre-Guerra","year":"2021","unstructured":"Llibre-Guerra JJ, Lee SE, Suemoto CK, Ehrenberg AJ, Kovacs GG, Karydas A et al (2021) A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD\/ALS-TDP. Brain Pathol 31:267\u2013282. https:\/\/doi.org\/10.1111\/bpa.12924","journal-title":"Brain Pathol"},{"key":"2531_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113. https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"key":"2531_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2531_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/NEN.0000000000000151","volume":"74","author":"PT Nelson","year":"2015","unstructured":"Nelson PT, Wang W-X, Partch AB, Monsell SE, Valladares O, Ellingson SR et al (2015) Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol 74:75\u201384","journal-title":"J Neuropathol Exp Neurol"},{"key":"2531_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137\u2013149. https:\/\/doi.org\/10.1007\/s00401-008-0477-9","journal-title":"Acta Neuropathol"},{"key":"2531_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-016-1610-9","volume":"132","author":"AM Nicholson","year":"2016","unstructured":"Nicholson AM, Rademakers R (2016) What we know about TMEM106B in neurodegeneration. Acta Neuropathol 132:639\u2013651. https:\/\/doi.org\/10.1007\/s00401-016-1610-9","journal-title":"Acta Neuropathol"},{"key":"2531_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jnc.12329","volume":"126","author":"AM Nicholson","year":"2013","unstructured":"Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB 3rd, Castanedes-Casey M et al (2013) TMEM106B p. T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J Neurochem 126:781\u2013791. https:\/\/doi.org\/10.1111\/jnc.12329","journal-title":"J Neurochem"},{"key":"2531_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-022-02486-5","volume":"144","author":"J Perneel","year":"2022","unstructured":"Perneel J, Rademakers R (2022) Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease. Acta Neuropathol 144:807\u2013819.\u00a0https:\/\/doi.org\/10.1007\/s00401-022-02486-5","journal-title":"Acta Neuropathol"},{"key":"2531_CR28","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1093\/hmg\/ddn257","volume":"17","author":"R Rademakers","year":"2008","unstructured":"Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ et al (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631\u20133642. https:\/\/doi.org\/10.1093\/hmg\/ddn257","journal-title":"Hum Mol Genet"},{"key":"2531_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12945","volume":"31","author":"R Rademakers","year":"2021","unstructured":"Rademakers R, Nicholson AM, Ren Y, Koga S, Nguyen HP, Brooks M et al (2021) Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits. Brain Pathol 31:e12945. https:\/\/doi.org\/10.1111\/bpa.12945","journal-title":"Brain Pathol"},{"key":"2531_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cels.2017.02.009","volume":"4","author":"H Rhinn","year":"2017","unstructured":"Rhinn H, Abeliovich A (2017) Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes. Cell Syst 4:404-415.e5. https:\/\/doi.org\/10.1016\/j.cels.2017.02.009","journal-title":"Cell Syst"},{"key":"2531_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1212\/WNL.0b013e318264e3ac","volume":"79","author":"NJ Rutherford","year":"2012","unstructured":"Rutherford NJ, Carrasquillo MM, Li M, Bisceglio G, Menke J, Josephs KA et al (2012) TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease. Neurology 79:717\u2013718. https:\/\/doi.org\/10.1212\/WNL.0b013e318264e3ac","journal-title":"Neurology"},{"key":"2531_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/alzrt247","volume":"6","author":"J Satoh","year":"2014","unstructured":"Satoh J, Kino Y, Kawana N, Yamamoto Y, Ishida T, Saito Y et al (2014) TMEM106B expression is reduced in Alzheimer\u2019s disease brains. Alzheimers Res Ther 6:17. https:\/\/doi.org\/10.1186\/alzrt247","journal-title":"Alzheimers Res Ther"},{"key":"2531_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/002215549904700601","volume":"47","author":"SA Schnell","year":"1999","unstructured":"Schnell SA, Staines WA, Wessendorf MW (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719\u2013730. https:\/\/doi.org\/10.1177\/002215549904700601","journal-title":"J Histochem Cytochem"},{"key":"2531_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser M, Arseni D, Bacioglu M, Huang M, L\u00f6vestam S, Shi Y et al (2022) Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605:310\u2013314. https:\/\/doi.org\/10.1038\/s41586-022-04650-z","journal-title":"Nature"},{"key":"2531_CR35","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/brain\/awx314","volume":"140","author":"C Simons","year":"2017","unstructured":"Simons C, Dyment D, Bent SJ, Crawford J, D\u2019Hooghe M, Kohlsch\u00fctter A et al (2017) A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy. Brain 140:3105\u20133111. https:\/\/doi.org\/10.1093\/brain\/awx314","journal-title":"Brain"},{"key":"2531_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bpa.12903","volume":"31","author":"S Stroobants","year":"2021","unstructured":"Stroobants S, D\u2019Hooge R, Damme M (2021) Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction. Brain Pathol 31:223\u2013238. https:\/\/doi.org\/10.1111\/bpa.12903","journal-title":"Brain Pathol"},{"key":"2531_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.25486","volume":"85","author":"TF Tropea","year":"2019","unstructured":"Tropea TF, Mak J, Guo MH, Xie SX, Suh E, Rick J et al (2019) TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia. Ann Neurol 85:801\u2013811. https:\/\/doi.org\/10.1002\/ana.25486","journal-title":"Ann Neurol"},{"key":"2531_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-013-1240-4","volume":"127","author":"M van Blitterswijk","year":"2014","unstructured":"van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC et al (2014) TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol 127:397\u2013406. https:\/\/doi.org\/10.1007\/s00401-013-1240-4","journal-title":"Acta Neuropathol"},{"key":"2531_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM van Deerlin","year":"2010","unstructured":"van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR et al (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42:234\u2013239. https:\/\/doi.org\/10.1038\/ng.536","journal-title":"Nat Genet"},{"key":"2531_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00401-010-0782-y","volume":"121","author":"R Vass","year":"2011","unstructured":"Vass R, Ashbridge E, Geser F, Hu WT, Grossman M, Clay-Falcone D et al (2011) Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol 121:373\u2013380. https:\/\/doi.org\/10.1007\/s00401-010-0782-y","journal-title":"Acta Neuropathol"},{"key":"2531_CR41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/brain\/awaa141","volume":"143","author":"X Zhou","year":"2020","unstructured":"Zhou X, Nicholson AM, Ren Y, Brooks M, Jiang P, Zuberi A et al (2020) Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies. Brain 143:1905\u20131919. https:\/\/doi.org\/10.1093\/brain\/awaa141","journal-title":"Brain"}],"updated-by":[{"DOI":"10.1007\/s00401-022-02536-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000}}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-022-02531-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-022-02531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T01:28:28Z","timestamp":1676338108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-022-02531-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2531"],"URL":"https:\/\/doi.org\/10.1007\/s00401-022-02531-3","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00401-022-02536-y","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00401-022-02536-y","URL":"https:\/\/doi.org\/10.1007\/s00401-022-02536-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Rademakers is a member of the Scientific Advisory Board of Arkuda Therapeutics and receives invention royalties from a patent related to progranulin. Dr. Mackenzie is a member of the Scientific Advisory Board of Prevail Therapeutics and receives invention royalties from a patent related to progranulin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}